10:45 ET - While deals in the pharmaceuticals space made up the lions share of healthcare deals each of the last few years, devices and services M&A has been the bright spot in terms of deal flow this year. On Monday, lab equipment maker Thermo Fisher Scientific (TMO) agreed to buy Patheon (PTHN) for $5.2B. That comes just weeks after device maker Becton Dickinson's (BDX) $24B deal to buy CR Bard (BCR). The services space has also been busy, with recent trades of Air Methods (AIRM), VWR (VWR) and INC Research (INCR). TMO shares are up 0.9% to $173; PTHN jumps 33% to $34.57. (dana.mattioli@wsj.com; @DanaMattioli)

(END) Dow Jones Newswires

May 15, 2017 11:00 ET (15:00 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Bard C R (NYSE:BCR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bard C R Charts.
Bard C R (NYSE:BCR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bard C R Charts.